Global Disease Control and Prevention Vaccine Sales Market Report 2021

Publisher Name :
Date: 14-May-2021
No. of pages: 115
Inquire Before Buying

The global Disease Control and Prevention Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Disease Control and Prevention Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Live-Attenuated

- Inactivated

- Recombinant Sub Unit and Toxoid

Segment by Application

- Pediatric Vaccine

- Adult Vaccine

The Disease Control and Prevention Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Disease Control and Prevention Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- GSK

- Merck & Co., Inc

- Pfizer

- Sanofi

- AstraZeneca PLC

- Sinovac Biotech Ltd

- Astellas Pharma Inc

- Serum Institute of India Pvt. Ltd

- Daiichi Sankyo

Global Disease Control and Prevention Vaccine Sales Market Report 2021

Table of Contents
1 Disease Control and Prevention Vaccine Market Overview
1.1 Disease Control and Prevention Vaccine Product Scope
1.2 Disease Control and Prevention Vaccine Segment by Type
1.2.1 Global Disease Control and Prevention Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Disease Control and Prevention Vaccine Segment by Application
1.3.1 Global Disease Control and Prevention Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Disease Control and Prevention Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Disease Control and Prevention Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Disease Control and Prevention Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Disease Control and Prevention Vaccine Price Trends (2016-2027)
2 Disease Control and Prevention Vaccine Estimates and Forecasts by Region
2.1 Global Disease Control and Prevention Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Disease Control and Prevention Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Disease Control and Prevention Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Disease Control and Prevention Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Disease Control and Prevention Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Disease Control and Prevention Vaccine Estimates and Projections (2016-2027)
2.4.3 China Disease Control and Prevention Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Disease Control and Prevention Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Disease Control and Prevention Vaccine Estimates and Projections (2016-2027)
2.4.6 India Disease Control and Prevention Vaccine Estimates and Projections (2016-2027)
3 Global Disease Control and Prevention Vaccine Competition Landscape by Players
3.1 Global Top Disease Control and Prevention Vaccine Players by Sales (2016-2021)
3.2 Global Top Disease Control and Prevention Vaccine Players by Revenue (2016-2021)
3.3 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2020)
3.4 Global Disease Control and Prevention Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Disease Control and Prevention Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Disease Control and Prevention Vaccine Market Size by Type
4.1 Global Disease Control and Prevention Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Disease Control and Prevention Vaccine Price by Type (2016-2021)
4.2 Global Disease Control and Prevention Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Disease Control and Prevention Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Disease Control and Prevention Vaccine Price Forecast by Type (2022-2027)
5 Global Disease Control and Prevention Vaccine Market Size by Application
5.1 Global Disease Control and Prevention Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Disease Control and Prevention Vaccine Price by Application (2016-2021)
5.2 Global Disease Control and Prevention Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Disease Control and Prevention Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Disease Control and Prevention Vaccine Price Forecast by Application (2022-2027)
6 North America Disease Control and Prevention Vaccine Market Facts & Figures
6.1 North America Disease Control and Prevention Vaccine Sales by Company
6.1.1 North America Disease Control and Prevention Vaccine Sales by Company (2016-2021)
6.1.2 North America Disease Control and Prevention Vaccine Revenue by Company (2016-2021)
6.2 North America Disease Control and Prevention Vaccine Sales Breakdown by Type
6.2.1 North America Disease Control and Prevention Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Disease Control and Prevention Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Disease Control and Prevention Vaccine Sales Breakdown by Application
6.3.1 North America Disease Control and Prevention Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Disease Control and Prevention Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Disease Control and Prevention Vaccine Market Facts & Figures
7.1 Europe Disease Control and Prevention Vaccine Sales by Company
7.1.1 Europe Disease Control and Prevention Vaccine Sales by Company (2016-2021)
7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Company (2016-2021)
7.2 Europe Disease Control and Prevention Vaccine Sales Breakdown by Type
7.2.1 Europe Disease Control and Prevention Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Disease Control and Prevention Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Disease Control and Prevention Vaccine Sales Breakdown by Application
7.3.1 Europe 115 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 115 Sales Breakdown by Application (2022-2027)
8 China Disease Control and Prevention Vaccine Market Facts & Figures
8.1 China Disease Control and Prevention Vaccine Sales by Company
8.1.1 China Disease Control and Prevention Vaccine Sales by Company (2016-2021)
8.1.2 China Disease Control and Prevention Vaccine Revenue by Company (2016-2021)
8.2 China Disease Control and Prevention Vaccine Sales Breakdown by Type
8.2.1 China Disease Control and Prevention Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Disease Control and Prevention Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Disease Control and Prevention Vaccine Sales Breakdown by Application
8.3.1 China 142 Sales Breakdown by Application (2016-2021)
8.3.2 China 142 Sales Breakdown by Application (2022-2027)
9 Japan Disease Control and Prevention Vaccine Market Facts & Figures
9.1 Japan Disease Control and Prevention Vaccine Sales by Company
9.1.1 Japan Disease Control and Prevention Vaccine Sales by Company (2016-2021)
9.1.2 Japan Disease Control and Prevention Vaccine Revenue by Company (2016-2021)
9.2 Japan Disease Control and Prevention Vaccine Sales Breakdown by Type
9.2.1 Japan Disease Control and Prevention Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Disease Control and Prevention Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Disease Control and Prevention Vaccine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Disease Control and Prevention Vaccine Market Facts & Figures
10.1 Southeast Asia Disease Control and Prevention Vaccine Sales by Company
10.1.1 Southeast Asia Disease Control and Prevention Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Disease Control and Prevention Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Disease Control and Prevention Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Disease Control and Prevention Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Disease Control and Prevention Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Disease Control and Prevention Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Disease Control and Prevention Vaccine Market Facts & Figures
11.1 India Disease Control and Prevention Vaccine Sales by Company
11.1.1 India Disease Control and Prevention Vaccine Sales by Company (2016-2021)
11.1.2 India Disease Control and Prevention Vaccine Revenue by Company (2016-2021)
11.2 India Disease Control and Prevention Vaccine Sales Breakdown by Type
11.2.1 India Disease Control and Prevention Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Disease Control and Prevention Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Disease Control and Prevention Vaccine Sales Breakdown by Application
11.3.1 India Disease Control and Prevention Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Disease Control and Prevention Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Disease Control and Prevention Vaccine Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Disease Control and Prevention Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Merck & Co., Inc
12.2.1 Merck & Co., Inc Corporation Information
12.2.2 Merck & Co., Inc Business Overview
12.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Products Offered
12.2.5 Merck & Co., Inc Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Disease Control and Prevention Vaccine Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Disease Control and Prevention Vaccine Products Offered
12.4.5 Sanofi Recent Development
12.5 AstraZeneca PLC
12.5.1 AstraZeneca PLC Corporation Information
12.5.2 AstraZeneca PLC Business Overview
12.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Products Offered
12.5.5 AstraZeneca PLC Recent Development
12.6 Sinovac Biotech Ltd
12.6.1 Sinovac Biotech Ltd Corporation Information
12.6.2 Sinovac Biotech Ltd Business Overview
12.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products Offered
12.6.5 Sinovac Biotech Ltd Recent Development
12.7 Astellas Pharma Inc
12.7.1 Astellas Pharma Inc Corporation Information
12.7.2 Astellas Pharma Inc Business Overview
12.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Products Offered
12.7.5 Astellas Pharma Inc Recent Development
12.8 Serum Institute of India Pvt. Ltd
12.8.1 Serum Institute of India Pvt. Ltd Corporation Information
12.8.2 Serum Institute of India Pvt. Ltd Business Overview
12.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products Offered
12.8.5 Serum Institute of India Pvt. Ltd Recent Development
12.9 Daiichi Sankyo
12.9.1 Daiichi Sankyo Corporation Information
12.9.2 Daiichi Sankyo Business Overview
12.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Products Offered
12.9.5 Daiichi Sankyo Recent Development
13 Disease Control and Prevention Vaccine Manufacturing Cost Analysis
13.1 Disease Control and Prevention Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Disease Control and Prevention Vaccine
13.4 Disease Control and Prevention Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Disease Control and Prevention Vaccine Distributors List
14.3 Disease Control and Prevention Vaccine Customers
15 Market Dynamics
15.1 Disease Control and Prevention Vaccine Market Trends
15.2 Disease Control and Prevention Vaccine Drivers
15.3 Disease Control and Prevention Vaccine Market Challenges
15.4 Disease Control and Prevention Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Disease Control and Prevention Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Disease Control and Prevention Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Disease Control and Prevention Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Disease Control and Prevention Vaccine Sales (K Units) by Region (2016-2021)
Table 5. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Disease Control and Prevention Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Disease Control and Prevention Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Disease Control and Prevention Vaccine Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Disease Control and Prevention Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Disease Control and Prevention Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Disease Control and Prevention Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Disease Control and Prevention Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Disease Control and Prevention Vaccine Sales Share by Company (2016-2021)
Table 14. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Disease Control and Prevention Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Disease Control and Prevention Vaccine as of 2020)
Table 17. Global Disease Control and Prevention Vaccine Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Disease Control and Prevention Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Disease Control and Prevention Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Disease Control and Prevention Vaccine Sales (K Units) by Type (2016-2021)
Table 22. Global Disease Control and Prevention Vaccine Sales Share by Type (2016-2021)
Table 23. Global Disease Control and Prevention Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Type (2016-2021)
Table 25. Global Disease Control and Prevention Vaccine Sales Share by Type (2022-2027)
Table 26. Global Disease Control and Prevention Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Disease Control and Prevention Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Type (2022-2027)
Table 29. Global Disease Control and Prevention Vaccine Sales (K Units) by Application (2016-2021)
Table 30. Global Disease Control and Prevention Vaccine Sales Share by Application (2016-2021)
Table 31. Global Disease Control and Prevention Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Application (2016-2021)
Table 33. Global Disease Control and Prevention Vaccine Sales (K Units) by Application (2022-2027)
Table 34. Global Disease Control and Prevention Vaccine Sales Share by Application (2022-2027)
Table 35. Global Disease Control and Prevention Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Disease Control and Prevention Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Application (2022-2027)
Table 38. North America Disease Control and Prevention Vaccine Sales (K Units) by Company (2016-2021)
Table 39. North America Disease Control and Prevention Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Disease Control and Prevention Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Disease Control and Prevention Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Disease Control and Prevention Vaccine Sales by Type (2016-2021) & (K Units)
Table 43. North America Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Disease Control and Prevention Vaccine Sales by Type (2022-2027) & (K Units)
Table 45. North America Disease Control and Prevention Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Disease Control and Prevention Vaccine Sales by Application (2016-2021) & (K Units)
Table 47. North America Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Disease Control and Prevention Vaccine Sales by Application (2022-2027) & (K Units)
Table 49. North America Disease Control and Prevention Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Disease Control and Prevention Vaccine Sales (K Units) by Company (2016-2021)
Table 51. Europe Disease Control and Prevention Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Disease Control and Prevention Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Disease Control and Prevention Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Disease Control and Prevention Vaccine Sales by Type (2016-2021) & (K Units)
Table 55. Europe Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Disease Control and Prevention Vaccine Sales by Type (2022-2027) & (K Units)
Table 57. Europe Disease Control and Prevention Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Disease Control and Prevention Vaccine Sales by Application (2016-2021) & (K Units)
Table 59. Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Disease Control and Prevention Vaccine Sales by Application (2022-2027) & (K Units)
Table 61. Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Disease Control and Prevention Vaccine Sales (K Units) by Company (2016-2021)
Table 63. China Disease Control and Prevention Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Disease Control and Prevention Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Disease Control and Prevention Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Disease Control and Prevention Vaccine Sales by Type (2016-2021) & (K Units)
Table 67. China Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Disease Control and Prevention Vaccine Sales by Type (2022-2027) & (K Units)
Table 69. China Disease Control and Prevention Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Disease Control and Prevention Vaccine Sales by Application (2016-2021) & (K Units)
Table 71. China Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Disease Control and Prevention Vaccine Sales by Application (2022-2027) & (K Units)
Table 73. China Disease Control and Prevention Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Disease Control and Prevention Vaccine Sales (K Units) by Company (2016-2021)
Table 75. Japan Disease Control and Prevention Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Disease Control and Prevention Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Disease Control and Prevention Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Disease Control and Prevention Vaccine Sales by Type (2016-2021) & (K Units)
Table 79. Japan Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Disease Control and Prevention Vaccine Sales by Type (2022-2027) & (K Units)
Table 81. Japan Disease Control and Prevention Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Disease Control and Prevention Vaccine Sales by Application (2016-2021) & (K Units)
Table 83. Japan Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Disease Control and Prevention Vaccine Sales by Application (2022-2027) & (K Units)
Table 85. Japan Disease Control and Prevention Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Disease Control and Prevention Vaccine Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Disease Control and Prevention Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Disease Control and Prevention Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Disease Control and Prevention Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Disease Control and Prevention Vaccine Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Disease Control and Prevention Vaccine Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Disease Control and Prevention Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Disease Control and Prevention Vaccine Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Disease Control and Prevention Vaccine Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Disease Control and Prevention Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Disease Control and Prevention Vaccine Sales (K Units) by Company (2016-2021)
Table 99. India Disease Control and Prevention Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Disease Control and Prevention Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Disease Control and Prevention Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Disease Control and Prevention Vaccine Sales by Type (2016-2021) & (K Units)
Table 103. India Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Disease Control and Prevention Vaccine Sales by Type (2022-2027) & (K Units)
Table 105. India Disease Control and Prevention Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Disease Control and Prevention Vaccine Sales by Application (2016-2021) & (K Units)
Table 107. India Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Disease Control and Prevention Vaccine Sales by Application (2022-2027) & (K Units)
Table 109. India Disease Control and Prevention Vaccine Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. GSK Disease Control and Prevention Vaccine Product
Table 114. GSK Recent Development
Table 115. Merck & Co., Inc Corporation Information
Table 116. Merck & Co., Inc Description and Business Overview
Table 117. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Merck & Co., Inc Disease Control and Prevention Vaccine Product
Table 119. Merck & Co., Inc Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Disease Control and Prevention Vaccine Product
Table 124. Pfizer Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Sanofi Disease Control and Prevention Vaccine Product
Table 129. Sanofi Recent Development
Table 130. AstraZeneca PLC Corporation Information
Table 131. AstraZeneca PLC Description and Business Overview
Table 132. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. AstraZeneca PLC Disease Control and Prevention Vaccine Product
Table 134. AstraZeneca PLC Recent Development
Table 135. Sinovac Biotech Ltd Corporation Information
Table 136. Sinovac Biotech Ltd Description and Business Overview
Table 137. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product
Table 139. Sinovac Biotech Ltd Recent Development
Table 140. Astellas Pharma Inc Corporation Information
Table 141. Astellas Pharma Inc Description and Business Overview
Table 142. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Astellas Pharma Inc Disease Control and Prevention Vaccine Product
Table 144. Astellas Pharma Inc Recent Development
Table 145. Serum Institute of India Pvt. Ltd Corporation Information
Table 146. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Serum Institute of India Pvt. Ltd Description and Business Overview
Table 148. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product
Table 149. Serum Institute of India Pvt. Ltd Recent Development
Table 150. Daiichi Sankyo Corporation Information
Table 151. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Daiichi Sankyo Description and Business Overview
Table 153. Daiichi Sankyo Disease Control and Prevention Vaccine Product
Table 154. Daiichi Sankyo Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Disease Control and Prevention Vaccine Distributors List
Table 158. Disease Control and Prevention Vaccine Customers List
Table 159. Disease Control and Prevention Vaccine Market Trends
Table 160. Disease Control and Prevention Vaccine Market Drivers
Table 161. Disease Control and Prevention Vaccine Market Challenges
Table 162. Disease Control and Prevention Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Disease Control and Prevention Vaccine Product Picture
Figure 2. Global Disease Control and Prevention Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Live-Attenuated Product Picture
Figure 4. Inactivated Product Picture
Figure 5. Recombinant Sub Unit and Toxoid Product Picture
Figure 6. Global Disease Control and Prevention Vaccine Sales Market Share by Application in 2021 & 2027
Figure 7. Pediatric Vaccine Examples
Figure 8. Adult Vaccine Examples
Figure 9. Global Disease Control and Prevention Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Disease Control and Prevention Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Disease Control and Prevention Vaccine Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Disease Control and Prevention Vaccine Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Disease Control and Prevention Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Disease Control and Prevention Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Disease Control and Prevention Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Disease Control and Prevention Vaccine Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Disease Control and Prevention Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Disease Control and Prevention Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Disease Control and Prevention Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Disease Control and Prevention Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Disease Control and P
  • Global Anti-PCSK9 Monoclonal Antibody Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 132
    The global Anti-PCSK9 Monoclonal Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-PCSK9 Monoclonal Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Alizumab - Evol......
  • Global Anti-TNF-a Monoclonal Antibody Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 133
    The global Anti-TNF-? Monoclonal Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-TNF-? Monoclonal Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Adalimumab - Go......
  • Global Anti-PD-1 MAb Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 137
    The global Anti-PD-1 MAb market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-PD-1 MAb market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 40mg - 100mg - 200mg - Others......
  • Global Warfarin Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 144
    The global Warfarin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Warfarin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 1mg/Tablet - 2.5mg/Tablet - 3mg/Tablet - 5mg/......
  • Global Trigeminal Neuralgia Treatment Medicine Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 140
    The global Trigeminal Neuralgia Treatment Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Trigeminal Neuralgia Treatment Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Carb......
  • Global HDAC (histone deacetylase) Inhibitor Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 133
    The global HDAC (histone deacetylase) Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HDAC (histone deacetylase) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Belinostat......
  • Global Chidamide Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 136
    The global Chidamide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chidamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 5 mg - Others Segment by Application......
  • Global Cattle Encephalon Glycoside and Ignotin Injection Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 139
    The global Cattle Encephalon Glycoside and Ignotin Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cattle Encephalon Glycoside and Ignotin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment b......
  • Global Monosialyltetrahexose Ganglioside Sodium Injection Sales Market Report 2021
    Published: 21-Jun-2021        Price: US 4000 Onwards        Pages: 135
    The global Monosialyltetrahexose Ganglioside Sodium Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monosialyltetrahexose Ganglioside Sodium Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs